Ekonomski rezultati

Impact of a patient blood management monitoring and feedback programme on allogeneic blood transfusions and related costs. (otvara novi prozor)

Kaserer A, Rössler J, Braun J, Farokhzad F, Pape HC, Dutkowski P, Plass A, Horisberger T, Volbracht J, Manz MG, Spahn DR

Izvor‎: Anaesthesia 2019;74(12):1534-41.

Indeks‎: PubMed 31448406

DOI‎: 10.1111/anae.14816

https://www.ncbi.nlm.nih.gov/pubmed/31448406 (otvara novi prozor)

Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia. (otvara novi prozor)

Kaur MN, Arnold DM, Heddle NM, Cook RJ, Hsia C, Blostein M, Jamula E, Sholzberg M, Lin Y, Kassis J, Larratt L, Tinmouth A, Carruthers J, Li N, Liu Y, Xie F

Izvor‎: Blood Adv. 2022;6(3):785-92.

Indeks‎: PubMed 34781363

DOI‎: 10.1182/bloodadvances.2021005627

https://pubmed.ncbi.nlm.nih.gov/34781363/ (otvara novi prozor)

HEMATOLOGIJA

Ekonomski rezultati

srpski (latinica)

Ekonomski rezultati

https://assetsnffrgf-a.akamaihd.net/assets/ct/1add6d1d93/images/syn_placeholder_sqr.png

Impact of a patient blood management monitoring and feedback programme on allogeneic blood transfusions and related costs. (otvara novi prozor)

Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia. (otvara novi prozor)

Kontakt s lokalnim predstavnicima (OOB)

Medicinske informacije

Filmovi

Ekonomski rezultati

Impact of a patient blood management monitoring and feedback programme on allogeneic blood transfusions and related costs. (otvara novi prozor)

Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia. (otvara novi prozor)

Kontakt s lokalnim predstavnicima (OOB)

Medicinske informacije

Filmovi

Izaberi jezik

Podeli